Martin Zentgraf
Vorstandsvorsitzender bei Desitin Arzneimittel GmbH
Profil
Martin Zentgraf currently works at Desitin Arzneimittel GmbH, as Managing Director and Bourne Capital Partners LLC (Private Equity), as Senior Advisor from 2022.
Dr. Zentgraf received his graduate degree in 1985 from the University of Münster.
Aktive Positionen von Martin Zentgraf
Unternehmen | Position | Beginn |
---|---|---|
Desitin Arzneimittel GmbH
Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Vorstandsvorsitzender | 10.10.2011 |
Bourne Capital Partners LLC (Private Equity)
Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Berater | 01.01.2022 |
Ausbildung von Martin Zentgraf
University of Münster | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Desitin Arzneimittel GmbH
Desitin Arzneimittel GmbH Pharmaceuticals: MajorHealth Technology Desitin Arzneimittel GmbH manufactures pharmaceutical products for neurological and psychiatric illnesses. Its products are geared towards the treatment of epilepsy, migraine and Parkinson's disease. The company was founded in 1919 and is headquartered in Hamburg, Germany. | Health Technology |
Bourne Capital Partners LLC (Private Equity)
Bourne Capital Partners LLC (Private Equity) Investment ManagersFinance Bourne Capital Partners LLC (Bourne Partners) is a private equity firm founded in 2001 by Banks Bourne. The firm is headquartered in Charlotte, North Carolina. | Finance |